Table 2. Baseline Psychosocial, Geriatric, and Patient Reported Characteristics of Participants According to Self-Reported Moderate Physical Activity: SAGE-AF Study.
Abbreviations; MOCA: Montreal Cognitive Assessment; PHQ9: Patient Health Questionnaire 9; GAD7: Generalized Anxiety Disorder; AFEQT: Atrial Fibrillation Effect on Quality of Life; ACTS: Anticoagulation Treatment Satisfaction; TTR: Time in Therapeutic Range
| Baseline Characteristics | Moderate Physical Activity | P-value | |
|---|---|---|---|
| Yes (n=652) | No (n=592) | ||
| Psychosocial and Geriatric | |||
| Gait Speed (%) | |||
| Normal | 539 (83) | 347 (59) | <0.001 |
| Slow | 111 (17) | 245 (41) | |
| Frailty (%) | |||
| Not frail | 391 (60) | 22 (4) | <0.001 |
| Pre-frail | 248 (38) | 411 (69) | |
| Frail | 13 (2) | 159 (27) | |
| Cognitive Impairment (MOCA≤23) (%) | 229 (35) | 299 (51) | <0.001 |
| Social Isolation (%) | 60 (9) | 96 (16) | <0.001 |
| Depression (PHQ9 ≥ 5) (%) | 143 (22) | 210 (36) | <0.001 |
| Anxiety (GAD-7 ≥5) (%) | 131 (20) | 160 (27) | <0.01 |
| Fall in Past 6 months (%) | 126 (19) | 144 (24) | 0.03 |
| Sensory Deficits (%) | |||
| Visual Impairment | 193 (30) | 235 (40) | <0.001 |
| Hearing Impairment | 243 (37) | 208 (35) | 0.45 |
| Patient Reported Outcomes | |||
| AFEQT | |||
| Score (M, SD) | 84 (16) | 76 (19) | <0.001 |
| ACTS (M, SD) | |||
| Burden Score | 17 (6) | 17 (6) | 0.76 |
| Benefit Score | 11 (4) | 10 (4) | <0.001 |
| TTR (warfarin), mean, time (SD) | 0.5 (0.4) | 0.5 (0.4) | 0.34 |
| Health Behavior | |||
| Current smoker (%) | 15 (2) | 20 (3) | 0.14 |